GSDMs are emerging as attractive checkpoints for immune response, inflammation, cancer, and autoimmune disorders, in addition to their involvement in a multitude of systemic conditions.3,13,14 In recent years, significant strides have been taken in the development of small molecule inhibitors targeting GSDMD. This evidence concerns the gene GSDMD and cancer.